Asthma Therapeutics Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography
상품코드:1935152
리서치사:Coherent Market Insights
발행일:2026년 01월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
천식 치료제 시장은 2026년에 204억 4,000만 달러로 추정되며, 2033년까지 233억 달러에 이를 전망입니다. 2026-2033년 연평균 복합 성장률(CAGR)은 1.9%로 예측되고 있습니다.
보고서의 내용
보고서 상세
기준 연도 :
2025년
2026년 시장 규모 :
204억 4,000만 달러
과거 데이터 대상 기간 :
2020-2024년
예측 기간 :
2026-2033년
예측 기간(2026-2033년) CAGR :
1.90%
2033년 예측 :
233억 달러
천식은 폐의 기도에 염증과 협착을 일으키는 장기적인 염증성 질환입니다. 기도 내벽의 부종과 염증, 기침, 호흡곤란, 가슴 압박감 등 다양한 증상이 특징입니다. 천식은 알레르기성 천식, 비알레르기성 천식, 성인 발병 천식, 운동 유발성 천식(신체 활동 시 발생), 야간 천식, 직업성 천식 등 여러 가지 유형으로 나뉩니다. 야간 천식은 야간형 천식이라고도 합니다. 매우 심각한 유형의 천식이기 때문에 적절한 진단과 치료가 필요합니다.
시장 역학
주요 기업들의 분무기 신제품 출시 증가는 세계 천식 치료제 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2018년 10월, Koninklijke Philips N.V.는 북미에서 새로운 메쉬 분무기 'InnoSpire Go'의 출시를 발표했습니다. 천식을 포함한 호흡기 질환 치료에 사용됩니다. 휴대용 휴대용 분무기 시스템으로 단시간에 치료가 가능한 휴대용 분무기 시스템입니다. 단 4분 만에 약물을 투여합니다. InnoSpire Go는 성인과 어린이 모두를 위해 설계되었습니다.
그러나 제품 회수는 천식 치료제 시장 성장의 주요 억제요인으로 시장 성장을 저해할 것으로 예측됩니다. 예를 들어, 2018년 8월 미국 식품의약국(FDA)은 캠버 파마슈티컬스(Camber Pharmaceuticals)의 몬테루카스트 나트륨 정제에 대해 제품 회수 경보를 발령했습니다. 이 정제는 몬테루카스트나트륨정 병에 잘못된 의약품(로사르탄칼륨정)이 함유되어 회수되었습니다.
본 조사의 주요 특징
이 보고서는 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 동안 전 세계 천식 치료제 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대한 상세한 분석을 제공합니다.
본 보고서에서는 다양한 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보도 제공합니다.
이 보고서는 기업 개요, 재무 성과, 제품 포트폴리오, 지리적 확장, 유통 전략, 주요 개발 및 전략과 같은 매개 변수를 기반으로 세계 천식 치료제 시장의 주요 기업 프로파일을 제공합니다.
이 보고서는 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 정부 정책, 기술 업그레이드, 시장 확대, 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
이 세계 천식 치료제 시장 보고서는 투자자, 제품 제조업체, 유통업체, 공급업체, 연구 및 컨설팅 회사, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자에게 유용한 정보를 제공합니다.
목차
제1장 조사 목적과 가정
제2장 시장 개요
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 천식 치료제 시장 : 약제 클래스별, 2026-2033년
제5장 세계의 천식 치료제 시장 : 투여 경로별, 2026-2033년
제6장 세계의 천식 치료제 시장 : 유통 채널별, 2026-2033년
제7장 세계의 천식 치료제 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
LSH
영문 목차
영문목차
Asthma Therapeutics Market is estimated to be valued at USD 20.44 Bn in 2026 and is expected to reach USD 23.30 Bn by 2033, growing at a compound annual growth rate (CAGR) of 1.9% from 2026 to 2033.
Report Coverage
Report Details
Base Year:
2025
Market Size in 2026:
USD 20.44 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2026 To 2033
Forecast Period 2026 to 2033 CAGR:
1.90%
2033 Value Projection:
USD 23.30 Bn
Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.
Market Dynamics
Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.
However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).
Key features of the study
This report provides in-depth analysis of the global asthma therapeutics market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global asthma therapeutics market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
Corticosteroids
Beta2-Agonists (Long-Acting and Short-Acting)
Leukotriene Inhibitors
Long-Acting Muscarinic Antagonists (LAMA)
Interleukin Antagonists
Anti-Immunoglobulin E (IgE) Agents
Combination Products
Others
Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
Oral, Inhalation
Injection
Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
GlaxoSmithKline Plc.
Philips Healthcare
AstraZeneca Plc.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH,
Sanofi-Aventis SA
CareFusion Corporation
Sunovion Pharmaceuticals, Inc.
Merck & Co., Inc.
Roche Diagnostics
Table of Contents
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Epidemiology
Product Recalls
Government Initiatives
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER'S Five Forces
PEST Analysis
4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Corticosteroids
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Beta2-Agonists (Long-Acting and Short-Acting)
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Leukotriene Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Long-Acting Muscarinic Antagonists (LAMA)
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Interleukin Antagonists
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Anti-Immunoglobulin E (IgE) Agents
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Combination Products
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)
Oral
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Inhalation
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Injection
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Hospitals Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Retail Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Online Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
US.
Canada
Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
UK.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
North Africa
Central Africa
South Africa
Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
